The MIA-Lab researchers collaborate with Jessica Mandrioli, to study the role of the microbiota-immunity axis in amyotrophic lateral sclerosis (ALS) (Geniality, NeuralStop, MysticAls) This collaboration integrates our expertise in microbiota research and immunology with Prof. Mandrioli’s clinical experience in ALS. Together, the team explores how alterations in the gut microbiota influence immune responses, potentially contributing to ALS pathogenesis and progression. This partnership bridges fundamental microbiome research with clinical applications, contributing to a deeper understanding of ALS mechanisms and exploring microbiome-based therapeutic strategies.
